Equity Overview
Price & Market Data
Price: $2.01
Daily Change: +$0.0244 / 1.21%
Daily Range: $1.88 - $2.10
Market Cap: $152,815,600
Daily Volume: 187,253
Performance Metrics
1 Week: 36.73%
1 Month: -36.99%
3 Months: -93.27%
6 Months: -95.78%
1 Year: -86.60%
YTD: -49.11%
Company Details
Employees: 29
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.